Efficacy and Safety of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: Results of the ZEUS Trial

被引：0
|
作者：
Pietruck, F.
Becker, T.
Arns, W.
Sommerer, C.
Reinke, P.
Eisenberger, U.
Fischer, W. [1 ]
Kramer, S. [1 ]
Budde, K.
机构：
[1] Novartis Pharmaceut, Nurnberg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：499 / 499
页数：1
相关论文
共 50 条
  • [41] Prospective study comparing gastrointestinal disorders in de novo renal-transplant patients receiving mycophenolate mofetil or enteric-coated mycophenolate sodium
    Kamar, N
    Oufroukhi, L
    Faure, P
    Ribes, D
    Cointault, O
    Lavayssière, L
    Durand, D
    Rostaing, L
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V164 - V164
  • [42] Prospective study comparing gastrointestinal disorders in de novo renal-transplant patients receiving mycophenolate mofetil or enteric-coated mycophenolate sodium
    Kamar, N
    Oufroukhi, L
    Faure, P
    Nogier, MB
    Cointault, O
    Lavayssiere, L
    Durand, D
    Rostaing, L
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 329 - 329
  • [43] Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: Results of a 12-month mulitcentre, open-label, prospective study.
    Vitko, S
    Vogt, B
    Antoniadis, A
    Klinger, M
    Kirchher, B
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 191 - 192
  • [44] Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: Results of a 12-month multicenter, open-label, prospective study
    Vogt, B.
    Antoniadis, A.
    Klinger, M.
    Vitko, S.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1301 - 1306
  • [45] Enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients: Pharmacokinetic (PK) results.
    Sechaud, R
    Yeh, CM
    Balez, S
    Koelle, E
    Hummel, M
    Gerosa, G
    Yonan, N
    Ross, H
    Miller, LW
    Brambilla, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 250 - 250
  • [46] Enteric-Coated Mycophenolate Sodium Reduces Gastrointestinal Symptoms in Renal Transplant Patients
    Burg, M.
    Saeemann, M. D.
    Wieser, C.
    Kramer, S.
    Fischer, W.
    Lhotta, K.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4159 - 4164
  • [47] Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of an Initially Intensified-Dosing Regimen of Enteric-Coated Mycophenolate Sodium Versus a Standard Dosing Regimen in Renal Transplant Patients.
    Budde, K.
    Arns, W.
    Glander, P.
    Sommerer, C.
    Ariatabar, T.
    Vogel, E. -M.
    Fischer, W.
    Zeier, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 417 - 417
  • [48] Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients
    Ricart, Maria J.
    Oppenheimer, Frederic
    Andres, Amado
    Morales, Jose M.
    Alonso, Angel
    Fernandez, Constantino
    [J]. CLINICAL TRANSPLANTATION, 2012, 26 (03) : 424 - 431
  • [49] Tolerance of Enteric-Coated Mycophenolate Sodium in Combination With Calcineurin Inhibitor in Kidney Transplant Recipients: Polish Experience
    Gozdowska, J.
    Urbanowicz, A. L.
    Galazka, Z.
    Chmura, A.
    Durlik, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (08) : 2946 - 2949
  • [50] 12 MONTH FOLLOW UP RESULTS OF AN INITIAL INTENSIFIED DOSING REGIMEN OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Arns, W.
    Kuypers, D.
    Tedesco Silva, H.
    Budde, K.
    Shoker, A.
    Prestele, H.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 81 - 82
12345